← Open Payments lookup

JAMIE KARRH: Open Payments

NPI 1992455661 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,065 in 49 payments from 10 companies in 2025. Trend: 2023 $1,499 · 2024 $1,254 · 2025 $1,065

Food & beverage: $1,065
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.18$285
Vanda Pharmaceuticals Inc.4$199
Teva Pharmaceuticals USA, Inc.9$156
Neurocrine BioSciences, Inc.4$129
Otsuka America Pharmaceutical, Inc.3$83
ABBVIE INC.4$72
Alkermes, Inc.3$70
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$35
Takeda Pharmaceuticals U.S.A., Inc.1$18
Janssen Pharmaceuticals, Inc1$17

Products named: COBENFY, FANAPT, INGREZZA, UZEDY, ABILIFY ASIMTUFII, VRAYLAR, ARISTADA, AUSTEDO XR.

Industry payments across FL — which companies pay providers there.